Xi-Feng Lu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bladder cancer is the most common urologic malignancy in China, with an increase of the incidence and mortality rates over past decades. Recent studies suggest that bladder tumors are maintained by a rare fraction of cells with stem cell proprieties. Targeting these bladder tumor initiating cell (TICs) population can overcome the drug-resistance of bladder(More)
  • 1